China Biotech Services Holdings Limited (HKG:8037)

Market Cap	604.95M -27.9%
Revenue (ttm)	73.50M +4.2%
Net Income	-68.78M
EPS	-0.07
Shares Out	975.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190,000
Open	0.6050
Previous Close	0.6150
Day's Range	0.6000 - 0.6250
52-Week Range	0.3000 - 1.3300
Beta	-0.66
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About HKG:8037

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People’s Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron n...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1996
• Employees: 149
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8037

Financial Performance

In 2025, HKG:8037's revenue was 73.50 million, an increase of 4.25% compared to the previous year's 70.51 million. Losses were -68.78 million, -65.29% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error